Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 3 29-3, 2003, Pages

  Zhang, Shen ^a   Fantozzi, Ivana ^a   Tigno, Donna D ^a   Yi, Eunhee S ^b   Platoshyn, Oleksandr ^a   Thistlethwaite, Patricia A ^c   Kriett, Jolene M ^c   Yung, Gordon ^a   Rubin, Lewis J ^a   Yuan, Jason X J ^a,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UCSD MEDICAL CENTER   (United States)

Author keywords

Arteries; Bcl; Hypertension; Smad; Transforming growth factor

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR; OSTEOGENIC PROTEIN 1; PROTEIN BCL 2; SMAD PROTEIN;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; LUNG VASOCONSTRICTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 17944386754     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00284.2002     Document Type: Article

References (65)

1. Adam JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998.
2. Akiyoshi S, Inoue H, Hanai J, Kusanagi K, Nemoto N, Miyazono K, and Kawabata M. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem 274: 35269-35277, 1999.
3. Archer S and Rich S. Primary pulmonary hypertension: a vascular biology and translational research "work in progress." Circulation 102: 2781-2791, 2000.
4. Atkinson C, Stewart S, Upton P, Machado R, Thomson J, Trembath R, and Morrell N. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation 105: 1672-1678, 2002.
5. Beppu H, Kawabata M, Hamamoto T, Chytil A, Minowa O, Noda T, and Miyazono K. BMP type II receptor is required for gastrulation and early development of mouse embryos. Dev Biol 221: 249-258, 2000.
6. Cook SA, Sugden PH, and Clerk A. Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential. Circ Res 85: 940-949, 1999.
7. Cowan KN, Heilbut A, Humpl T, Lam C, Ito S, and Rabinovitch M. Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor. Nat Med 6: 698-702, 2000.
8. Cowan KN, Jones PL, and Rahinovitch M. Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis. Circ Res 84: 1223-1233, 1999.
9. De Caestecker M and Meyrick B. Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension. Respir Res 2: 193-197, 2001.
10. Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, Kalachikov S, Cayanis E, Fischer SG, Barst RJ, Hodge SE, and Knowles JA. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 67: 737-744, 2000.
11. Dorai H, Vukicevic S, and Sampath TK. Bone morphogenetic protein-7 (OP-1) inhibits smooth muscle cell proliferation and stimulates the expression of markers that are characteristic of SMC phenotype in vitro. J Cell Physiol 184: 37-45, 2000.
12. + channel activity and enhances survival in vascular smooth muscle cells. Am J Physiol Cell Physiol 281: C157-C165, 2001.
13. 2+/calmodulin-dependent kinase II phophorylates the epidermal growth factor receptor on multiple sites in the cytoplasmic tail and serine 744 within the kinase domain to regulate signal generation. J Biol Chem 274: 16168-16173, 1999.
14. Fine A, Janssen-Heininger Y, Soultanakis RP, Swisher SG, and Uhal B. Apoptosis in lung pathophysiology. Am J Physiol Lung Cell Mol Physiol 279: L423-L427, 2000.
15. Fishman AP. Etiology and pathogenesis of primary pulmonary hypertension. Chest 114 Suppl 3: 242S-247S, 1998.
16. Geraci M, Moore M, Gesell T, Yeager M, Alger L, Golpon H, Gao B, Loyd J, Tuder R, and Voelkel N. Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis. Circ Res 88: 555-562, 2001.
17. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI, and Knaus P. Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Mol Biol Cell 11: 1023-1035, 2000.
18. Hata A, Lagna G, Massague J, and Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186-197, 1998.
19. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A, and Massague J. OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100: 229-240, 2000.
20. Haunstetter A and Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82: 1111-1129, 1998.
21. He H, Lam M, McCormick TS, and Distelhorst CW. Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2. J Cell Biol 138: 1219-1228, 1997.
22. Heldin CH, Miyazono K, and ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997.
23. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, and Miyazono K. Smad6 inhibits signalling by the TGF-β superfamily. Nature 389: 622-626, 1997.
24. Ishisaki A, Yamato K, Hashimoto S, Nakao A, Tamaki K, Nonaka K, ten Dijke P, Sugino H, and Nishihara T. Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem 274: 13637-13642, 1999.
25. Ishisaki A, Yamato K, Nakao A, Nonaka K, Ohguchi M, ten Dijke P, and Nishihara T. Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells. J Biol Chem 273: 24293-24296, 1998.
26. Isner JM, Kearney M, Bortman S, and Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation 91: 2703-2711, 1995.
27. Jena N, Martin-Seisdedos C, McCue P, and Croce CM. BMP7 null mutation in mice: developmental defects in skeleton, kidney, and eye. Exp Cell Res 230: 28-37, 1997.
28. Kluck RM, Bossy-Wetzel E, Green DR, and Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
29. Knaus P and Sebald W. Cooperativity of binding epitopes and receptor chains in the BMP/TGF-β superfamily. J Biol Chem 382: 1189-1195, 2001.
30. + channels induces apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol 280: C970-C979, 2001.
31. 2+ fluxes. Proc Natl Acad Sci USA 91: 6569-6573, 1994.
32. Lane K, Machado R, Pauciulo M, Thomson J, Phillips J, Loyd J, Nichols W, and Trembath R. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 26: 81-84, 2000.
33. Luo K, Stroschein SL, Wang W, Chen D, Martens E, Zhou S, and Zhou Q. The ski oncoprotein interacts with the Smad proteins to repress TGF-β signaling. Genes Dev 13: 2196-2206, 1999.
34. Machado R, Pauciulo M, Thomson J, Lane K, Morgan N, Wheeler L, Phillips J, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranehjaerg L, Loyd J, Trembath R, and Nichols W. BMPR2 haploin-sufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68: 92-102, 2001.
35. Massague J and Chen YG. Controlling TGF-β signaling. Genes Dev 14: 627-644, 2000.
36. Maasague J and Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J 19: 1745-1754, 2000.
37. Miyazono K, Kusanagi K, and Inoue H. Divergence and convergence of TFG-β/BMP signaling. J Cell Physiol 187: 265-276, 2001.
38. 1 and bone morphogenetic proteins. Circulation 104: 790-795, 2001.
39. Nakaoka T, Gonda K, Ogita T, Otawara-Hamamoto Y, Okabe F, Kira Y, Harii K, Miyazono K, Takuwa Y, and Fujita T. Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. J Clin Invest 100: 2824-2832, 1997.
40. Narayan P, Mentzer R, and Lasley R. Annexin V staining during reperfusion detects cardiomyocytes with unique properties. Am J Physiol Heart Circ Physiol 281: H1931-H1937, 2001.
41. Newman J, Wheeler L, Lane K, Loyd E, Gaddipati R, Phillips J, and Loyd J. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in large kindred. N Engl J Med 345: 319-324, 2001.
42. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis Y, and Knaus P. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338, 2002.
43. Rabinovitch M. Elastase and the pathobiology of unexplained pulmonary hypertension. Chest 114, Suppl 3: 213S-224S, 1998.
44. Rosenzweig BL, Imamura T, Okadome T, Cox GN, Yamashita H, ten Dijke P, Heldin CH, and Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92: 7632-7636, 1995.
45. Rubin LJ and Rich S. Primary Pulmonary Hypertension. New York: Marcel Dekker, 1997.
46. Rudarakandhana N, Flanagan JA, Chen H, Upton PD, Machado R, Patel D, Trembath RC, and Morrell NW. Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension. Hum Mol Genet 11: 1517-1525, 2002.
47. Saed GM and Diamond MP. Apoptosis and proliferation of human peritoneal fibroblasts in response to hypoxia. Fertil Steril 78: 137-143, 2002.
48. Shi Y. Structural insights on Smad function in TGF-β signaling. Bioessays 23: 223-232, 2001.
49. Shimizu S, Eguchi Y, Kamiiki W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, and Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA 95: 1455-1459, 1998.
50. Stenmark KR and Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89-144, 1997.
51. Sun Y, Liu X, Ng-Eaton E, Lodish HF, and Weinberg RA. SnoN and Ski protooneoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci USA 96: 12442-12447, 1999.
52. Susin SA, Zamzami N, Castedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, and Kroemer G. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331-1341, 1996.
53. Ten Dijke P, Miyazono K, and Heldin CH. Signaling inputs converge on nuclear effectors in TGF-β signaling. Trends Biochem Sci 25: 64-70, 2002.
54. Uhal BD. Apoptosis in lung fibrosis and repair. Chest 122, Suppl 6: 293S-298S, 2002.
55. Voelkel NF and Tuder RM. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension. Pul Pharmacol Ther 10: 231-241, 1997.
56. Von Budnoff A and Cho KWY. Intracellular BMP signaling regulation in vertebrates: pathway or network. Dev Biol 239: 1-14, 2001.
57. Wong GA, Tang V, El-Sabeawy F, and Weiss RH. BMP-2 inhibits proliferation of human aortic smooth muscle cells via p21Cip1/Waf1. Am J Physiol Endocrinol Metab 284: E972-E979, 2003.
58. Wordinger RJ, Agarwal R, Talati M, Fuller J, Lambert W, and Clark AF. Expression of bone morphogenetic protein (BMP), BMP receptors, and BMP associated proteins in human trabecular meshwork and optic nerve head cells and tissues. Mol Vis 8: 241-250, 2002.
59. Wotton D, Lo RS, Lee S, and Massague J. A smad transcriptional corepressor. Cell 97: 29-39, 1999.
60. Yamamura Y, Hua X, Bergelson S, and Lodish HF. Critical role of SMADs and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J Biol Chem 275: 36295-36302, 2000.
61. Yanagisawa K, Osada H, Masuda A, Kondo M, Saito T, Yatabe Y, Takagi K, Takahashi T, and Takahashi T. Induction of apoptosis by SMAD3 and down-regulation of SMAD3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene 17: 1732-1747, 1998.
62. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
63. + channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 98: 1400-1406, 1998.
64. + channel gene transcription in primary pulmonary hypertension. Lancet 351: 726-727, 1998.
65. Zimmerman CM, Kariapper MS, and Mathews LS. Smad proteins physically interact with calmodulin. J Biol Chem 273: 677-680, 1998.